Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 843 blog entries.

July 2026

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development

2026-07-30T14:25:50+00:00

Indica Labs today announces the launch of the ADC Target Scoring module for the HALO® image analysis platform, a powerful new functionality that supports the development of next-generation precision oncology therapies through quantitative target scoring and spatial analysis. Antibody-drug conjugates (ADC) have emerged as one of the most promising classes of precision oncology therapeutics, combining targeted delivery with the [...]

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development2026-07-30T14:25:50+00:00

The Foundation for Laboratory Innovation Starts in the Cloud

2026-08-10T07:55:16+00:00

How modern LIMS platforms help laboratories adapt, scale, and innovate with confidence. The emergence of Agentic AI systems and advanced Data Analytics is accelerating digital transformation across scientific laboratories—demanding faster, smarter ways of working. Faced with rising test volumes, growing test complexity, tighter compliance demands, and tightening budgets, many labs have responded by layering on point solutions. The [...]

The Foundation for Laboratory Innovation Starts in the Cloud2026-08-10T07:55:16+00:00

PathAI Advances AISight® Dx with the v2.21 Release: Intelligent Dashboard Controls, Enhanced Data Organization, & Enterprise-Scale Configurability

2026-08-10T07:55:07+00:00

We're thrilled to announce the release of AISight® Dx v2.21, the latest update to PathAI's FDA-cleared digital pathology platform. This release represents a significant leap forward in customizability, putting intelligence and control in the hands of every user - from individual clinicians to lab administrators managing enterprise-scale operations. This release delivers dashboard customization, powerful slide review [...]

PathAI Advances AISight® Dx with the v2.21 Release: Intelligent Dashboard Controls, Enhanced Data Organization, & Enterprise-Scale Configurability2026-08-10T07:55:07+00:00

Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis

2026-08-10T07:54:58+00:00

Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast biomarker quantification suite, seamlessly deployed in HALO AP®. This enhanced new version introduces fully automated identification and exclusion of positive control tissue, ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), [...]

Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis2026-08-10T07:54:58+00:00

Toward Comprehensive Cellular Characterization of H&E Slides

2026-08-10T07:54:48+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics | ScienceDirect.com by Elsevier. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Benjamin Adjadja,b, [...]

Toward Comprehensive Cellular Characterization of H&E Slides2026-08-10T07:54:48+00:00

Future of Healthcare is Digital, Nigeria Must Not Be Left Behind — Dr Dawodu

2026-07-30T08:32:09+00:00

By Sade Oguntola Dr Olayemi Dawodu, laboratory physician and the Chief Executive officer of Cerba-Lancet Laboratories Nigeria, in this interview with Sade Oguntola, says AI, telepathology and government support are key to reaching underserved communities. DIAGNOSTIC laboratories played a critical role during the COVID-19 pandemic. What lessons has Cerba Lancet Nigeria carried forward from that [...]

Future of Healthcare is Digital, Nigeria Must Not Be Left Behind — Dr Dawodu2026-07-30T08:32:09+00:00

The Dutch Nationwide Pathology Databank and Its Central Role in Health Research

2026-07-29T09:50:27+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics | ScienceDirect.com by Elsevier. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Albert G. [...]

The Dutch Nationwide Pathology Databank and Its Central Role in Health Research2026-07-29T09:50:27+00:00

Virasoft Receives U.S. FDA 510(k) Clearance for ViraSight, Expanding Its Enterprise Pathology Platform

2026-07-30T14:29:49+00:00

FDA 510(k) clearance authorizes ViraSight for digital primary diagnosis using whole slide images scanned with the FDA-cleared Hamamatsu NanoZoomer S360MD and Leica Aperio GT450 DX systems. Virasoft joins a select group of companies offering FDA-cleared digital pathology software for primary diagnosis on multiple devices in the United States. ViraSight extends the Pathora enterprise pathology platform, enabling [...]

Virasoft Receives U.S. FDA 510(k) Clearance for ViraSight, Expanding Its Enterprise Pathology Platform2026-07-30T14:29:49+00:00

The Business of Pathology: Unlocking a Lab’s Value

2026-07-30T14:29:43+00:00

INDUSTRY INSIGHT from Signify Research Guest Authors:Alan Stoddart, Editor, Healthcare TechnologyImogen Fitt, Principal Analyst, Digital Laboratory and Lifesciences Digital pathology is a discipline of promise.Providers are promised that the adoption of digital pathology will make them more efficient, enable their pathologists to add greater value and take advantage of sophisticated solutions. These opportunities are real and [...]

The Business of Pathology: Unlocking a Lab’s Value2026-07-30T14:29:43+00:00

New Topology-based Biomarkers May Improve Breast Cancer Prediction

2026-07-29T09:40:51+00:00

By Columbia University Irving Medical Center Edited by Andrew Zinin For decades, pathologists have diagnosed and graded breast cancer by looking at tissue samples under a microscope, searching for telltale signs of disorder in the structure of cells and tissues. Now, researchers at Columbia and their collaborators have developed a new computational approach that transforms [...]

New Topology-based Biomarkers May Improve Breast Cancer Prediction2026-07-29T09:40:51+00:00
Go to Top